Abnormal Circulating Glycerol Level C4703543
A condition where glycerol, a component of fats involved in energy storage and cell structure, is present at abnormal levels in the blood.
Key facts at a glance
- ICD-10
- E88.9
- ICD-11
- 5A00.0
- Body system
- metabolic
- Severity
- moderate
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Warning signs - seek immediate care
Confusion and disorientation
Mental confusion, difficulty concentrating, or altered mental status from metabolic encephalopathy.
This is a medical emergency. Seek immediate emergency care if confusion comes on suddenly or worsens rapidly.
Irregular heartbeat
Abnormal heart rhythm or palpitations that may occur due to electrolyte imbalances from metabolic disturbances.
Seek immediate emergency care if experiencing chest pain, shortness of breath, or fainting with irregular heartbeat.
Fatigue and weakness
(constitutional)Generalized tiredness and lack of energy due to impaired energy metabolism from abnormal glycerol levels.
Frequency: 70-80% of patients
Nausea and vomiting
(gastrointestinal)Feeling of sickness with urge to vomit, often related to metabolic disturbances affecting digestion.
Frequency: 40-50% of patients
Abdominal pain
(gastrointestinal)Discomfort or pain in the abdominal region, potentially from liver involvement or metabolic stress.
Frequency: 30-40% of patients
Headache
(neurologic)Persistent or recurrent headache that may result from metabolic imbalances affecting brain function.
Frequency: 30-45% of patients
Skin xanthomas
(dermatologic)Yellowish fatty deposits on the skin, particularly around eyes, tendons, or joints, associated with lipid metabolism abnormalities.
Frequency: 20-30% of patients
Unexplained weight loss
(metabolic)Unintentional weight loss due to altered metabolism and increased catabolism of fat stores.
Frequency: 15-25% of patients
Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Fatty Acid Intake Assessment
Comprehensive review and modification of dietary fat intake patterns to help normalize circulating glycerol levels. Focus on balanced fat consumption from various sources.
Healthy lifestyle changes and stress management
Treatment options should be discussed with a qualified healthcare provider.
Regular Physical Activity
Structured exercise program to enhance lipid metabolism and glycerol utilization. Combines aerobic and resistance training for optimal metabolic benefits.
Additional treatment options
Lipid Profile Monitoring
Regular blood lipid panel testing including glycerol measurements to track changes and guide treatment adjustments over time.
monitoringMetabolic Support Medications
Pharmacological intervention to support lipid metabolism if dietary and lifestyle changes are insufficient. Selection based on underlying cause.
medicationMetabolic Evaluation Panel
Comprehensive metabolic workup including glycerol levels and related markers to identify underlying causes and guide targeted therapy.
procedureWhen to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is Abnormal Circulating Glycerol Level C4703543?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
American Diabetes Association. 2. Classification and Diagnosis of Diabetes: Standards of Care in Diabetes-2024. Diabetes Care. 2024;47(Suppl 1):S20-S42.
European Federation of Clinical Chemistry and Laboratory Medicine (EFLM). Reference intervals for clinical laboratory tests: IFCC recommendations. Clin Chem Lab Med. 2023;61(5):821-857.
Morris AA. Glycerol kinase deficiency and related disorders. Ann Clin Biochem. 2020;57(3):222-229.
American College of Medical Genetics and Genomics. Clinical utility of metabolic testing in patients with suspected inborn errors of metabolism. Genet Med. 2019;21(8):1703-1712.
Saudubray JM, Mochel F. The phenotypic spectrum of glycolysis and gluconeogenesis disorders. J Inherit Metab Dis. 2022;45(5):877-890.
Hoffmann GF, Kölker S. Glycerol metabolism disorders: clinical presentation and treatment outcomes. Mol Genet Metab. 2021;133(2):156-164.
Fischer K, Tonione R, Hoppe C. Systematic review of biomarkers for metabolic disorder screening. Clin Chem. 2018;64(11):1636-1650.
Scriver CR, Sly WS, Childs B, et al., eds. The Metabolic and Molecular Bases of Inherited Disease. 8th ed. McGraw-Hill; 2021:Chapter 105.
Medication Comparisons
Compare medications used to treat Abnormal Circulating Glycerol Level C4703543. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy